Christopher Peetz
CEO & DirectorMr. Christopher Peetz, also known as Chris, is Independent Director of Arcutis Biotherapeutics, Inc. from July 15, 2026. Mr. Peetz was Independent Director of Alpine Immune Sciences, Inc. from April 24, 2018. He joined the Alpine Immune Sciences, Inc. on April 24, 2018. He is CEO & Director of Mirum Pharmaceuticals, Inc. from January 2024. He was President, CEO & Director of Mirum Pharmaceuticals, Inc. from March 2019 to January 2024. He is Entrepreneur-in-Residence of Frazier Life Sciences Management, LP. He was Entrepreneur-in-Residence of Frazier Management, L.L.C. from May 30, 2017. He joined the Frazier Management, L.L.C. on May 30, 2017. He focused on Life Sciences. He was CFO & Head of Corporate Development of Tobira Therapeutics, Inc. He joined the Tobira Therapeutics, Inc. on March 26, 2014. He has B.S.B.A. in French, International Business & Finance from Washington University, St. Louis, M.B.A. from Stanford Graduate School of Business.
Positions
- Company NameMirum Pharmaceuticals, Inc.Stock CodeMIRMPositionCEO & DirectorColleagues
- MGMichael G. GreyIndependent Non-Executive Chairman of the Board
- PRPeter RadovichCOO & President
- EHEric H. BjerkholtChief Financial Officer
- JGJean-Luc GirardetChief Technical Officer
- AMAndrew McKibbenSenior Vice President, Strategic Finance & Investor Relations
- LFLaurent FischerIndependent Director
- LALaura A. BregeIndependent Director
- TPTimothy P. WalbertIndependent Director
